SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-20-008465
Filing Date
2020-03-03
Accepted
2020-03-03 16:59:04
Documents
77
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K atrs-10k_20191231.htm   iXBRL 10-K 3693983
2 EX-4.5 atrs-ex45_200.htm EX-4.5 14280
3 EX-23.1 atrs-ex231_11.htm EX-23.1 3416
4 EX-31.1 atrs-ex311_9.htm EX-31.1 15706
5 EX-31.2 atrs-ex312_10.htm EX-31.2 15826
6 EX-32.1 atrs-ex321_6.htm EX-32.1 6447
7 EX-32.2 atrs-ex322_7.htm EX-32.2 6364
8 GRAPHIC gs3fgrl0fzj0000001.jpg GRAPHIC 30211
  Complete submission text file 0001564590-20-008465.txt   12238673

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA atrs-20191231.xsd EX-101.SCH 62284
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atrs-20191231_cal.xml EX-101.CAL 72410
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atrs-20191231_def.xml EX-101.DEF 192261
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE atrs-20191231_lab.xml EX-101.LAB 523239
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atrs-20191231_pre.xml EX-101.PRE 383195
26 EXTRACTED XBRL INSTANCE DOCUMENT atrs-10k_20191231_htm.xml XML 2559118
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32302 | Film No.: 20683393
SIC: 3841 Surgical & Medical Instruments & Apparatus
Office of Life Sciences